Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. KTTA.NASDAQ

Pasithea Therapeutics Corp (KTTA NASDAQ) stock market data APIs

$5.02 -0.03(-0.6%) as of July 26, 2024
Price chart is built with Anychart

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Pasithea Therapeutics Corp Financial Data Overview

5.05
5.02
-
5.16
5.02
4.46-12.64
4 862 K
1 043 K
487 K
-3.7035
0.754
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KTTA',
Type: 'Common Stock',
Name: 'Pasithea Therapeutics Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01018ZGY8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1841330',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-09-15',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Pasithea Therapeutics Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 487 K
  • EBITDA -16 158 591
  • Earnings Per Share -13.74
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Pasithea Therapeutics Corp Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast NaN

Get Pasithea Therapeutics Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Pasithea Therapeutics Corp latest news via APIs

Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders

SOUTH SAN FRANCISCO, Calif. and MIAMI, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (NASDAQ: KTTA), today announced that its annual meeting of ...
  • AGM
  • ANNUAL GENERAL MEETING
  • ANNUAL MEETINGS & SHAREHOLDER RIGHTS
  • BIOTECHNOLOGY
  • KTTA
  • NASDAQ
  • NASDAQ:KTTA
  • PASITHEA
  • PASITHEA THERAPEUTICS

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

-- Company on track to submit PAS-004 IND application in current quarter -- -- Pasithea plans to begin PAS-004 Phase 1 dose escalation trial in advanced solid tumor patients harboring RAS, RAF and ...
  • ADVANCED SOLID TUMORS
  • BIOTECH
  • CLINICAL STUDY
  • CLINICAL TRIAL
  • DOSE ESCALATION
  • FDA
  • MANAGEMENT STATEMENTS
  • NASDAQ
  • NASDAQ:KTTA
  • NF1
  • PAS-004
  • PASITHEA
  • PRE-IND MEETING
  • RAF MUTATIONS
  • RAS MUTATIONS
Do you have any questions?
support@eodhistoricaldata.com